Fig. 5
From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations
Immune-related signature in the NTRK mutation and wild type of the NSCLC patients from TCGA. A-C: Infiltration frequencies of 22 types of immune cells in the NTRK, NTRK1, NTRK2, NTRK3 mutation and wild type. D-G: The expression of cytolytic activity related genes, immune checkpoint related genes and chemokine related genes in the NTRK, NTRK1, NTRK2, NTRK3 mutation and wild type of NSCLC patients from TCGA